Studying the diseases of the brain is a massive challenge for researchers as extracting brain cells, or neurons, from a living patient is difficult and risky. At the same time, examining a patient's brain post-mortem usually only reveals the disease's final stages. And animal models, while incredibly informative, have frequently fallen short during the crucial drug-development stage of research. But scientists at the Gladstone Institutes and the University of California, ...Saturday, 31 August 2013
Molecular Mechanism That may Cause Toxic Protein Buildup in Dementia Mapped
Studying the diseases of the brain is a massive challenge for researchers as extracting brain cells, or neurons, from a living patient is difficult and risky. At the same time, examining a patient's brain post-mortem usually only reveals the disease's final stages. And animal models, while incredibly informative, have frequently fallen short during the crucial drug-development stage of research. But scientists at the Gladstone Institutes and the University of California, ...
Australian PM Rudd makes last-ditch plea to voters as polls slip
By Rob Taylor CANBERRA (Reuters) - Australia's Prime Minister Kevin Rudd, struggling to avert a landslide election defeat in six days, pledged tax breaks and education programs on Sunday to counter a slowing economy in a last-ditch plea to voters. Rudd, promising a "New Way" in his main campaign launch in the battleground state of Queensland, sought to capitalize on unease among voters about promised conservative opposition spending cuts, warning they would hurt jobs and confidence. "In this election we are now engaged in the fight of our lives," he told thousands of cheering supporters. ...
via Health News Headlines - Yahoo! News Read More Here..
New Daiichi drug vies for slice of clot prevention market
By Ben Hirschler AMSTERDAM (Reuters) - A new clot preventer from Daiichi Sankyo proved as effective as widely used warfarin in treating a dangerous condition known as venous thromboembolism and caused less bleeding, a large clinical trial found. The Japanese drugmaker hopes the finding will help it take on rivals including Bayer, Johnson & Johnson, Pfizer and Bristol-Myers Squibb in a growing market for novel pills to prevent blood clots. Industry analysts believe that modern blood thinners to replace warfarin could generate annual sales of more than $10 billion a year. ...
via Health News Headlines - Yahoo! News Read More Here..
Research Indicates Some Breast Cancer Cells Are Primed to Thrive
Some loose breast cancer cells are more likely to prosper in bone tissue due to the genes that they express, a team of researchers at the Howard Hughes Medical Institute (HHMI) has discovered. The team also found that whether or not cancer cells turn on those genes depends on what their surroundings were like in the primary breast tumor. If the breast tumor had molecular patterns similar to those found in bone, the tumor is more likely to spread to bone later. "It''s ...Health Consequences of 'Safe' Levels of Environmental Pollution Elaborated
New research indicates that pollution could be the reason if you are not seeing any health improvements despite eating better and exercising regularly. According to the research report published in the September issue of The FASEB Journal, what you are eating and doing may not be the problem, but what's in what you are eating could be the culprit. "This study adds evidences for rethinking the way of addressing risk assessment especially when considering ...New Daiichi drug vies for slice of clot prevention market
AMSTERDAM (Reuters) - A new clot preventer from Daiichi Sankyo proved as effective as widely used warfarin in treating a dangerous condition known as venous thromboembolism and caused less bleeding, a large clinical trial found.
via Reuters: Health News Read More Here..
20 years of Tylenol warning labels
WASHINGTON (AP) — The maker of Tylenol will begin adding a bold new warning to bottle caps of its best-selling pain reliever this fall to warn consumers about the risks of taking too much. Overdose from acetaminophen, the drug found in Tylenol, has been the leading cause of sudden liver failure in the U.S. for over a decade. Johnson & Johnson, which makes Tylenol, has periodically repackaged and relabeled Tylenol products in the past to try to reduce accidental liver damage. Here is a look at some changes the company has made over the last 20 years: via Health News Headlines - Yahoo! News Read More Here..
Radiation readings spike at water tank at Japan's ruined nuclear plant
TOKYO (Reuters) - Radiation at a tank holding highly contaminated water at Japan's crippled Fukushima nuclear plant has spiked 18-fold, the plant's operator said on Sunday. Radiation of 1,800 millisieverts per hour - enough to kill an exposed person in four hours - was detected near the bottom of one storage tank on Saturday, Tokyo Electric Power Co, also known as Tepco, said. An August 22 reading measured radiation of 100 millisieverts per hour at the same tank. A Tepco spokesman also said a new leak had been detected from a pipe connecting two other tanks. ...
via Health News Headlines - Yahoo! News Read More Here..
Subscribe to:
Comments (Atom)